Donovan MJ and colleagues, including Sanda MG, demonstrated that identifying exosomal PCA3 in urine and assessing T2:ERG expression levels in urine can aid in the early detection of prostate cancer, as well as monitoring disease progression and recurrence [19–21]. The gene discussed is PCA3; the disease is prostate carcinoma.